Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Colorcon

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for GS-0976


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug GS-0976?

GS-0976 is an investigational drug.

There have been 7 clinical trials for GS-0976. The most recent clinical trial was a Phase 2 trial, which was initiated on August 8th 2016.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Gilead Sciences, Novo Nordisk A/S, and Nimbus Apollo.

There are five US patents protecting this investigational drug and one hundred and one international patents.

Recent Clinical Trials for GS-0976
TitleSponsorPhase
Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)Novo Nordisk A/SPhase 2
Study Evaluating the Safety and Efficacy of Semaglutide, and the Fixed-Dose Combination of Cilofexor and Firsocostat, Alone and in Combination, in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)Gilead SciencesPhase 2
Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)Novo Nordisk A/SPhase 2

See all GS-0976 clinical trials

Clinical Trial Summary for GS-0976

Top disease conditions for GS-0976
Top clinical trial sponsors for GS-0976

See all GS-0976 clinical trials

US Patents for GS-0976

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GS-0976 ⤷  Sign up for a Free Trial Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof Gilead Apollo, LLC (Foster City, CA) ⤷  Sign up for a Free Trial
GS-0976 ⤷  Sign up for a Free Trial ACC inhibitors and uses thereof Gilead Apollo, LLC (Foster City, CA) ⤷  Sign up for a Free Trial
GS-0976 ⤷  Sign up for a Free Trial Processes for preparing ACC inhibitors and solid forms thereof Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign up for a Free Trial
GS-0976 ⤷  Sign up for a Free Trial ACC inhibitors and uses thereof Nimbus Apollo, Inc. (Cambridge, MA) ⤷  Sign up for a Free Trial
GS-0976 ⤷  Sign up for a Free Trial ACC inhibitors and uses thereof Gilead Apollo, LLC (Foster City, CA) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GS-0976

Drugname Country Document Number Estimated Expiration Related US Patent
GS-0976 Argentina AR107790 2036-03-02 ⤷  Sign up for a Free Trial
GS-0976 Australia AU2017226267 2036-03-02 ⤷  Sign up for a Free Trial
GS-0976 Brazil BR112018067408 2036-03-02 ⤷  Sign up for a Free Trial
GS-0976 Canada CA3015526 2036-03-02 ⤷  Sign up for a Free Trial
GS-0976 China CN108699078 2036-03-02 ⤷  Sign up for a Free Trial
GS-0976 China CN112920200 2036-03-02 ⤷  Sign up for a Free Trial
GS-0976 Eurasian Patent Organization EA201891692 2036-03-02 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.